Company intelligence / Profile preview

Qufora

Allerød, Zealand, Denmark

Ownership: Private
Employees: ~102
Development stage: Other

Overview

Qufora’s bowel irrigation solutions—such as IrriSedo, MiniGo, MiniGo Flex, and Klick—are CE-marked, widely used, and supported by ongoing clinical research and medical affairs; new pediatric product lines launched in 2024; clinical solution efficacy supported but most studies are device/real-world outcome focused.

Therapeutic areas: Gastroenterology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Impilo (ownership/financial backing)relationships with European healthcare systems (for reimbursement/distribution)

Beyond the preview

Go deeper on Qufora.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qufora.

Explore the full profile